• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nocturne Acquisition Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

    4/19/24 10:18:14 AM ET
    $MBTC
    Blank Checks
    Finance
    Get the next $MBTC alert in real time by email
    false 0001837344 00-0000000 0001837344 2024-04-17 2024-04-17 0001837344 MBTC:UnitsEachConsistingOfOneOrdinaryShareParValue0.0001AndOneRightMember 2024-04-17 2024-04-17 0001837344 MBTC:OrdinarySharesIncludedAsPartOfUnitsMember 2024-04-17 2024-04-17 0001837344 MBTC:RightsIncludedAsPartOfUnitsMember 2024-04-17 2024-04-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): April 17, 2024

     

    Nocturne Acquisition Corporation

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-40259   N/A
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (I.R.S. Employer
    Identification No.)

     

    P.O. Box 25739

    Santa Ana, CA

      91799
    (Address of principal executive offices)   (Zip Code)

     

    (650) 953-0312

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

     

    Title for each class   Trading Symbol(s)   Name of each exchange on
    which registered
    Units, each consisting of one Ordinary Share, par value $0.0001, and one right   MBTCU   The Nasdaq Stock Market LLC
             
    Ordinary Shares included as part of the Units   MBTC   The Nasdaq Stock Market LLC
             
    Rights included as part of the Units   MBTCR   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    As previously reported in the Current Report on Form 8-K filed on April 1, 2024, Nocturne Acquisition Corporation, a special purpose acquisition company incorporated as a Cayman Islands exempted company (“Nocturne” or the “Company”) was not able to complete the proposed merger with Cognos Therapeutics, Inc., a Delaware corporation (“Cognos”), pursuant to the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) by and among the Company, Nocturne Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Nocturne, and Cognos, as the Merger Agreement expired pursuant to its terms on March 31, 2024.

     

    The Company did not consummate an initial business combination before April 5, 2024, and pursuant to the Company’s Amended and Restated Memorandum and Articles of Association, the Company’s Board of Directors has determined to redeem the Company’s public Ordinary Shares, par value $0.0001 per share (“Ordinary Shares”), at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding publicly held Ordinary Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any).

      

    Item 8.01 Other Events.

     

    The information set forth above in Item 3.01 of this Current Report on Form 8-K is incorporated by reference herein.

     

    In order to provide for the disbursement of funds from the Company’s trust account, the Company will instruct Continental Stock Transfer & Trust Company, as trustee, to take all necessary actions to liquidate the assets held in the trust account. The proceeds thereof, less $100,000 of interest to pay dissolution expenses and net of taxes payable, will be held in a trust operating account while awaiting disbursement to the public holders of the Ordinary Shares (the “Redemption Amount”). All other costs and expenses associated with implementing the Company’s plan of dissolution will be funded from proceeds held outside of the trust account. The Company anticipates that the Redemption Amount will be paid to public holders of the Ordinary Shares on or about April 18, 2024, without any required action on their part, at which point such shares shall be redeemed and canceled and will only have the right to receive the Redemption Amount. Following such redemption, the Ordinary Shares will no longer be outstanding. Beneficial owners of the Ordinary Shares held in “street name,” will not need to take any action in order to receive their pro rata portion of the Redemption Amount. Registered holders of the public Ordinary Shares will need to present proof of their respective Ordinary Shares to the Company’s transfer agent, Continental Stock Transfer & Trust Company, to receive their pro rata portion of the Redemption Amount.

     

    1

     

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks, uncertainties, and assumptions that are difficult to predict. All statements other than statements of historical fact contained in this Current Report on Form 8-K, including statements regarding future events, our future financial performance, business strategy, and plans and objectives of management for future operations, are forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” or “should,” or the negative of these terms or other comparable terminology. The forward-looking statements made herein are based on the Company’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation, its limited operating history, competitive factors in the Company’s and Force’s industry and market, and other general economic conditions. The forward-looking statements made herein are based on the Company’s current expectations, assumptions, and projections, which could be incorrect. The forward-looking statements made herein speak only as of the date of this Current Report on Form 8-K and the Company undertakes no obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as otherwise required by law. The Company cautions you that these forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the Company’s periodic filings with the Securities and Exchange Commission (the “SEC”), including its most recent Annual Report on Form 10-K, and its subsequent Quarterly Reports on Form 10-Q. The Company’s SEC filings are available publicly on the SEC’s website at http://www.sec.gov.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
    99.1   Press Release dated April 17, 2024
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Nocturne Acquisition Corporation
         
    Dated: April 19, 2024 By: /s/ Henry Monzon
        Name:  Henry Monzon
        Title: Chief Executive Officer

     

     

    3

     

    Get the next $MBTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MBTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MBTC
    SEC Filings

    View All

    SEC Form 15-12G filed by Nocturne Acquisition Corporation

    15-12G - Nocturne Acquisition Corp (0001837344) (Filer)

    4/25/24 2:27:44 PM ET
    $MBTC
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Nocturne Acquisition Corporation

    25-NSE - Nocturne Acquisition Corp (0001837344) (Subject)

    4/25/24 9:09:49 AM ET
    $MBTC
    Blank Checks
    Finance

    Nocturne Acquisition Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

    8-K - Nocturne Acquisition Corp (0001837344) (Filer)

    4/19/24 10:18:14 AM ET
    $MBTC
    Blank Checks
    Finance

    $MBTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting

    SANTA ANA, CA / ACCESSWIRE / January 30, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the "Company"), announced today that the Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on January 30, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. The Extraordinary General Meeting will now be held virtually on February 6, 2024 at 10:00 a.m. Eastern Time, and the Company plans to continue to solicit proxies from shareholders during the period prior to the Extraordinary General Meeting. The record date for the Extraordinary General Meeting remains the close of business on

    1/30/24 8:31:00 AM ET
    $MBTC
    Blank Checks
    Finance

    Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing

    WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR))) ("Nocturne") and Cognos Therapeutics, Inc. ("Cognos") today announced the engagement of Chardan, a leading global investment bank, in the role of capital markets advisor to Nocturne in the highly anticipated business combination transaction (the "Business Combination") with Cognos. This strategic move marks Cognos's journey towards becoming a publicly traded company on the NASDAQ Stock Exchange. Chardan, a distinguished independent, full-service investment bank, boasts two decades of experience in addressing the diverse capital market requirements of bo

    9/20/23 6:35:54 PM ET
    $MBTC
    Blank Checks
    Finance

    Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Cognos

    Transaction Expected to Accelerate the Research and Advancement of Cognos' Proprietary and Innovative Implantable Drug Delivery Pump to Improve Outcomes for Treatment of Brain Cancers and Other Neurological DiseasesWILMINGTON, DE / ACCESSWIRE / August 16, 2023 / Nocturne Acquisition Corporation (NASDAQ:MBTC)(NASDAQ:MBTCU)(NASDAQ:MBTCR) (the "Company", "MBTC" or "Nocturne"), today announced the submission via Edgar, the U.S. Securities and Exchange Commission's ("SEC") online portal, for filing of a registration statement on Form S-4 (the "Registration Statement") with the SEC, which includes a preliminary proxy statement/prospectus in connection with the proposed business combination (the "B

    8/16/23 8:05:00 AM ET
    $MBTC
    Blank Checks
    Finance

    $MBTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Lin Haoyu claimed ownership of 3,340,000 units of Ordinary Shares (SEC Form 3)

    3 - Nocturne Acquisition Corp (0001837344) (Issuer)

    2/12/24 8:26:07 PM ET
    $MBTC
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Wong Ka Lok

    3 - Nocturne Acquisition Corp (0001837344) (Issuer)

    1/13/22 5:54:09 PM ET
    $MBTC
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Mangiacotti Giuseppe

    3 - Nocturne Acquisition Corp (0001837344) (Issuer)

    1/13/22 5:52:45 PM ET
    $MBTC
    Blank Checks
    Finance

    $MBTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Nocturne Acquisition Corporation (Amendment)

    SC 13G/A - Nocturne Acquisition Corp (0001837344) (Subject)

    3/11/24 7:53:12 PM ET
    $MBTC
    Blank Checks
    Finance

    SEC Form SC 13G filed by Nocturne Acquisition Corporation

    SC 13G - Nocturne Acquisition Corp (0001837344) (Subject)

    2/14/24 1:02:48 PM ET
    $MBTC
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Nocturne Acquisition Corporation (Amendment)

    SC 13G/A - Nocturne Acquisition Corp (0001837344) (Subject)

    2/5/24 4:48:19 PM ET
    $MBTC
    Blank Checks
    Finance